ENTRY       D00343                      Drug
NAME        Ifosfamide (JAN/USP/INN);
            Ifex (TN)
PRODUCT     IFEX (Baxter Healthcare Corporation)
            IFOSFAMIDE (Baxter Healthcare Corporation)
            IFOSFAMIDE (Baxter Healthcare Corporation)
  GENERIC   IFOSFAMIDE (Fresenius Kabi USA)
            IFOSFAMIDE (Fresenius Kabi USA)
            IFOSFAMIDE (Hikma Pharmaceuticals USA)
FORMULA     C7H15Cl2N2O2P
EXACT_MASS  260.0248
MOL_WEIGHT  261.086
CLASS       Antineoplastic
             DG01677  Alkylating agent
              DG01678  Nitrogen mustard analog
               DG01720  Isophosphoramide mustard analog
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07047
            Therapeutic category: 4211
            ATC code: L01AA06
            Product: D00343<JP/US>
EFFICACY    Antineoplastic, Alkylating agent
  DISEASE   Testicular cancer [DS:H00023]
COMMENT     Active form of prodrug: 4-Hydroxyifosfamide [CPD:C16553]
TARGET      DNA
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AA Nitrogen mustard analogues
                 L01AA06 Ifosfamide
                  D00343  Ifosfamide (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Ifosfamide
                D00343  Ifosfamide (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4211  Chlorethylamines
                 D00343  Ifosfamide (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01677  Alkylating agent
               DG01678  Nitrogen mustard analog
                DG01720  Isophosphoramide mustard analog
                 D00343  Ifosfamide
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00343  Ifosfamide
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00343
            Prodrugs [br08324.html]
             D00343
DBLINKS     CAS: 3778-73-2
            PubChem: 7847409
            ChEBI: 5864
            LigandBox: D00343
            NIKKAJI: J2.196B
ATOM        14
            1   P1a P    27.8304  -19.5949
            2   N1b N    27.8362  -18.1152
            3   N1y N    28.9741  -20.2612
            4   O2x O    26.6807  -20.2612
            5   O3b O    26.5511  -18.8521
            6   C1x C    28.9741  -21.5877
            7   C1x C    26.6807  -21.5877
            8   C1x C    27.8304  -22.2421
            9   C1b C    30.1794  -19.5230
            10  C1b C    31.4045  -20.2302
            11  X   Cl   32.6294  -19.5230
            12  C1b C    26.6476  -17.4300
            13  C1b C    25.4351  -18.1300
            14  X   Cl   24.2227  -17.4300
BOND        14
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 2
            5     3   6 1
            6     4   7 1
            7     6   8 1
            8     7   8 1
            9     3   9 1
            10    9  10 1
            11   10  11 1
            12    2  12 1
            13   12  13 1
            14   13  14 1
///
